HK Stock Market Move | POP MART (09992) rose by over 7% again, with a cumulative increase of over 20% in three days. Founder Duan Yongping became the second largest shareholder.
Puppy Mart (09992) surged more than 7% again, with a cumulative increase of over 20% in the past 3 trading days. As of press time, it rose 4.44% to 181.1 Hong Kong dollars, with a turnover of 4.33 billion Hong Kong dollars.
POP MART (09992) rose by more than 7% again, with a cumulative increase of over 20% over the past 3 trading days. As of the time of publication, it rose by 4.44% to 181.1 Hong Kong dollars, with a turnover of 4.133 billion Hong Kong dollars.
On the news front, on May 25th, Duan Yongping increased his holdings in POP MART through his H&H Fund, with Duan Yongping and his concerted action person holding a total of 76.3716 million shares, accounting for 5.69% of the total shares, becoming the second largest shareholder of POP MART, second only to the founder Wang Ning. Previously, Duan Yongping has publicly expressed optimism about POP MART.
Huachuang Securities pointed out that the company's core IP has maintained strong vitality, with excellent performance in the cooperation products of Labubu with Sanrio and Labubu with FIFA in Q1 2026. The Star series has achieved rapid growth, becoming a phenomenon-level IP in China and several Asian countries, once again verifying the company's IP operation capabilities. The firm pointed out that the current valuation of POP MART is less than 15x, with a discount compared to the valuations of IP companies in the primary and secondary markets.
Related Articles

RIMBACO (01953) released its interim performance, with a net profit of 15.753 million Malaysian Ringgit, a year-on-year increase of 398%.
.png)
Haisco Pharmaceutical Group (002653.SZ): Hydroxytyrosol injection has obtained FDA market approval.

HK Stock Market Move | LAOPU GOLD (06181) rose over 9% in the morning. LAOPU GOLD will open a new store in The Parisian Macao this year and accelerate its overseas expansion.
RIMBACO (01953) released its interim performance, with a net profit of 15.753 million Malaysian Ringgit, a year-on-year increase of 398%.

Haisco Pharmaceutical Group (002653.SZ): Hydroxytyrosol injection has obtained FDA market approval.
.png)
HK Stock Market Move | LAOPU GOLD (06181) rose over 9% in the morning. LAOPU GOLD will open a new store in The Parisian Macao this year and accelerate its overseas expansion.






